PATENT CLAIM ANALYSIS

Application Number: 15922278
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-03
Patent Classification: ["424", "463000"]

Abstract:
Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans.

Claim (Index 11):
A pharmaceutical enteric coated oral dosage form comprising:\n a. a zoledronic acid molecular complex, and b. a pharmaceutical acceptable excipient, where said the pharmaceutical enteric coated oral dosage form is suitable for oral administration and has an improved safety profile over the corresponding oral dosage form without an enteric coating.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13567827', '15288139', '15819191', '15609641', '12847568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8273994181864712
- 35 USC 102 Novelty (BERT): 0.6107083413987923
- Combined Prediction Score: 0.8057303105077034
- Mean Citation Score: 635.482208
- Max Citation Score: 689.8741
- Similarity Product: 458.8692139138699

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test